MicroRNAs regulate granulosa cells apoptosis and follicular development — A review

Abstract

Objective

MicroRNAs (miRNAs) are the most abundant small RNAs. Approximately 2,000 annotated miRNAs genes have been found to be differentially expressed in ovarian follicles during the follicular development (FD). Many miRNAs exert their regulatory effects on the apoptosis of follicular granulosa cells (FGCs) and FD. However, accurate roles and mechanism of miRNAs regulating apoptosis of FGCs remain undetermined.

Methods

In this review, we summarized the regulatory role of each miRNA or miRNA cluster on FGCs apoptosis and FD on the bases of 41 academic articles retrieved from PubMed and web of science and other databases.

Results

Total of 30 miRNAs and 4 miRNAs clusters in 41 articles were reviewed and summarized in the present article. Twenty nine documents indicated explicitly that 24 miRNAs and miRNAs clusters in 29 articles promoted or induced FGCs apoptosis through their distinctive target genes. The remaining 10 miRNAs and miRNAs of 12 articles inhibited FGCs apoptosis. MiRNAs exerted modulation actions by at least 77 signal pathways during FGCs apoptosis and FD.

Conclusion

We concluded that miRNAs or miRNAs clusters could modulate the apoptosis of GCs (including follicular GCs, mural GCs and cumulus cells) by targeting their specific genes. A great majority of miRNAs show a promoting role on apoptosis of FGCs in mammals. But the accurate mechanism of miRNAs and miRNA clusters has not been well understood. It is necessary to ascertain clearly the role and mechanism of each miRNA or miRNA cluster in the future. Understanding precise functions and mechanisms of miRNAs in FGCs apoptosis and FD will be beneficial in developing new diagnostic and treatment strategies for treating infertility and ovarian diseases in humans and animals.

INTRODUCTION

The first microRNA (miRNA) was discovered in the Caenorhabditis elegans by Ambros and Ruvkun in 1993 [1]. Later, a lot of miRNAs were discovered in human and animals [2]. The miRNAs are originally transcribed from coding genes which occupy 1% to 3% of the genome. Currently, approximately 2,000 annotated miRNAs have been reported in humans [3,4]. The miRNAs regulate about 30% of protein-coding genes in mammals since the different miRNAs may target the same mRNAs [5]. Nucleotides sizes of miRNAs are differentially reported in the mammals, including 19 to 22 nucleotides [6], 20 to 24 nucleotides [6,7], 21 to 23 nucleotide [4], and even 21 to 26 molecules [8]. Consequently, the precise numbers of nucleotides of miRNAs remain undetermined [9,10].

Roughly, 52% of human miRNAs are localized within the intergenic regions, 40% are located within intronic regions, and the rest 8% are situated within exons [11]. In mammals, most miRNAs regulate gene expression via combining the 3′-untranslated region (UTR) and the specific sequences of target mRNAs, causing repression of translation of target mRNAs [12–14]. One miRNA may target hundreds of different mRNAs. However, the regulatory mechanism of every miRNA remains unclearly understood [12].

Follicular granulosa cells (FGCs) play a key role in nourishing oocytes through secreting growth factors and hormones and regulating development of oocytes [15]. It has been well known that miRNAs exert the vital functions in FGCs apoptosis and follicular development (FD) [8,16,17]. The functions of specific miRNAs are implicated in different aspects of FGCs processes of the mammals, such as proliferation [18], differentiation [19], and cumulus expansion [20].

Previous studies aimed to determine the roles of miRNAs on the FD of mammals using various approaches, including conditional knockout of miRNA biogenesis genes, high-throughput sequencing technologies in various animal models. Nowadays, it has been well known that miRNAs exert a significant role in FD and oocyte development of mammals [8,21].

However, so far the accurate effects and regulatory mechanism of different miRNAs regulating apoptosis of granulosa cells (GCs) and FD have still remained unclear, especially their target genes and signaling pathways [20,22]. The present review aimed to comprehensively elaborate the research advances on miRNAs for modulating apoptosis of FGCs and FD in humans and animals so as to seek new diagnostic and treatment scheme for infertility and ovarian diseases.

miRNAs MODULATE APOPTOSIS OF FOLLICULAR GRANULOSA CELLS

The miRNAs regulate the function of FGCs via altering expression levels of target genes [7,23]. The microRNA (miR)-let-7 family is highly conserved in sequences across animal species. MiR-let-7 family is differentially expressed during follicular atresia [24]. Expression levels of miR-let-7a, let-7b, let-7c, and let-7i genes were reduced in early and progressed atretic follicles as compared to those in healthy follicles [25,26]. The miR-let-7g-mediated suppression of mitogen-activated protein kinase kinase kinase 1 (MAP3K1) resulted in the expression and dephosphorylation of the transcription factor fork head O1 (FOXO1) which induced FGCs apoptosis [27]. Overexpression of miR-let-7g increased the apoptosis rate of the mouse FGCs [26] and FOXO1 expression in FGCs, and then resulted in nuclear accumulation of dephosphorylated FOXO1. Additionally, the expression levels of the apoptosis-associated genes including Caspase 3, BCL2-Associated X (BAX), and BES1-interacting Myc-like protein (BIM) were significantly upregulated after miR-let-7g mimic was transfected into porcine FGCs. But the anti-apoptotic genes B-cell lymphoma-2 (Bcl-2) and myeloid cell leukemia-1 were significantly down-regulated [26]. Briefly, the miR-let-7 family exerted a potential in the regulation of FGCs apoptosis.

MiR-21 is one of three highly luteinizing hormone (LH) -induced miRNAs in murine FGCs [14]. It acts as an antiapoptotic factor in GCs. A loss of miR-21 in vivo leads to a reduction of ovulation rates [28]. MiR-21 blocks the apoptosis of murine FGCs [14,29]. Several miR-21 target transcripts have been identified to explain its antiapoptotic effect, including programmed cell death 4, phosphatase and tensin homologue [29,30].

The levels of the primary transcript of miR-21 (pri-miR-21) and mature miR-21 were obviously increased in the cumulus oocyte complexes (COCs) over the maturation period. The pri-miR-21 expression was remarkably decreased in COCs treated with a signal transducer and activator of transcription 3 pathway inhibitor, and cumulus expansion may be prevented. Inihibition of Pri-miR-21 expression directly influenced miR-21 expression in bovine oocytes and cumulus cells (CCs) [31]. Upregulating miR-21 expression significantly reduced CCs apoptosis. The oocyte-secreted factors (OSFs) upregulated miR-21 expression and suppressed FCCs apoptosis by activating the PI3K/Akt signal [29]. It is known that oocytes and CCs are more resistant to apoptosis than other compartments of the antral follicle. However, little is known about the intracellular mechanisms by which OSFs render FCCs resistant to apoptosis [29,32].

MiR-146a is implicated in ovarian cancer development by suppressing the expression of antiapoptotic genes, such as X-linked inhibitor of apoptosis protein, Bcl-2-like protein 2, and baculoviral IAP repeat containing 5 [33]. The downregulation of miR-146a inhibited apoptosis of FGCs by simultaneously targeting interleukin-1 receptor-associated kinase (IRAK1) [34]. A recent study demonstrated that miR-126 inhibited FSH receptor (a direct target gene) expression and increased the apoptosis rate of porcine FGCs [35]. However, the cell apoptosis rate was dramatically reduced when miR-141-3p was overexpressed in rat FGCs [36].

An earlier report revealed that miR-26b enhanced DNA breaks and FGCs apoptosis by targeting the ataxia telangiectasia mutated (ATM) gene [37]. Overexpression of miR-26b promoted porcine FGCs apoptosis by regulating the expression of Sma-and Mad-related 4 (SMAD4). These results strongly suggest that miR-26b plays a crucial role in FGCs apoptosis [37]. MiR-125b regulated apoptosis by targeting bone morphogenetic protein receptor 1B (BMPR1B) in yak FGCs [38].

The miR-144 was differentially expressed in the porcine preovulatory follicles. The miR-144 regulated FGCs apoptosis and affected follicular atresia [39]. Additionally, miR-224 was involved in the mouse FGCs proliferation via targeting SMAD4 [33]. Another study indicated that miR-1275 was expressed during the porcine follicular atresia. The miR-1275 can promote early apoptosis of porcine FGCs and the initiation of follicular atresia (FA) by inhibiting estradiol release and expression of liver receptor homolog (LRH)-1 that was bound to the cytochrome P450, family 19, subfamily A, polypeptide 1 promoter and increased its activity. Additionally, miR-1275 attenuated LRH-1 expression by directly binding to its 3′ UTR [40].

MiRNAs REGULATE DEVELOPMENT OF MURAL GCs AND CUMULUS CELLS

The GCs are divided and differentiated into mural GCs and CCs that tightly surround the oocyte [41,42]. Both mural GCs and CCs are two specialized cell types that differentiate from a common progenitor during folliculogenesis [43]. Mural FGCs supported the oocytes via endocrine and paracrine pathways [44]. The miRNAs are differentially expressed between CCs and mural GCs [45]. Another report showed that 59 miRNAs were found differentially expressed between bovine immature and maturated oocytes [46]. The sequencing analysis revealed the expression of several hundreds of miRNAs in mural GCs and CCs. 53 miRNAs (such as miR-146a-5p, miR-149-5p, miR-509-3p, and miR-182-5p) were differentially expressed between mural FGCs and CCs [43]. Top 10 most abundant miRNAs in mural GCs and CCs were miR-21-5p, let-7a-5p, let-7f-5p, miR-26a-5p, let-7b-5p, let-7g-5p, miR-103a-3p, miR-125a-5p, miR-92a-3p, miR-320a, and other miRNAs. MiR-146a-5p, miR-182-5p, miR-509-3p, and miR-149-5p exert their regulatory functions through 37, 43, 2, and 9 target genes, respectively [43].

Expression of miR-130b was altered during oocyte maturation by directly targeting SMAD5 and mitogen- and stress-activated protein kinase 1 which were identified as target genes of miR-130b. Overexpression of miR-130b increased the proliferation of mural GCs and CCs. But, inhibition of miR-130b expression during in vitro maturation (IVM) of oocytes decreased the first polar body extrusion and the mitochondrial activity. Such, functional modulation of miR-130b affected the proliferation and survival of GC and CC as well as oocyte maturation [47].

Previous studies also demonstrated miR-146a-5p promoting apoptosis of mural GCs by directly targeting IRAK1 and tumor necrosis factor receptor-associated factor 6 and miR-503-5p inhibiting proliferation by targeting cyclin D2 [48]. In 9 differentially expressed miRNAs, 4 miRNAs (hsa-miR-146a-5p, has-miR-10b-5p, hsa-miR-29b-3p, and hsa-miR-142-5p) in mural GCs, and 5 miRNAs (hsa-let-7c-5p, hsa-miR-125b-5p, hsa-miR-1275, hsa-miR-129-5p, and hsa-miR-129-2-3p) in CC were upregulated [43].

Overall together, studies on cell communication, extracellular matrix and signaling pathways have demonstrated the differential expressions of miRNAs have relevance with physiological functions of CCs and mural GCs [45].

MiRNAs REGULATE DEVELOPMENT OF OVARIAN FOLLICLES

Both FD and oocyte maturation are completed in the ovaries of female mammals. A highly complicated, spontaneous death phenomenon that is called as atresia takes place during the FD and maturation in the mammals. Follicular atresia is resulted from the apoptosis of GCs surrounding oocytes [49]. In mammals, less than 1% of ovarian follicles will eventually ovulate. More than 99% of ovarian follicles are disappeared as a result of atresia, which affects all stages of follicular growth and development [50].

The FD is mediated by various regulatory factors including many miRNAs [51]. Numerous miRNAs play important roles in follicular atresia and development [49,52]. The miRNAs exert their functions as mediators of these processes via their extensive involvement in post-transcriptional mRNA regulation [53,54]. The miRNAs are differentially expressed during the primordial development [55], luteal development [56] and the whole FD [54].

MiR-378 could affect oocyte IVM by inhibiting the expansion and altering gene expression of CCs, and adjust in estradiol production by depressing aromatase translation in porcine FGCs. The miR-378 decreased IVM rate, suppressed the expression of genes associated with FD, such as bone morphogenetic protein 15 and growth differentiation factor 9 and also increased apoptosis rate [21] since miR-378 targeted to the 3′-UTR of aromatase mRNA [57].

MiR-23a and miR-27a have been reported to promote GC apoptosis by targeting SMAD5 through the FasL-Fas-mediated pathway [8,58,59]. Knocking down SMAD5 expression increased the rate of apoptosis [59]. Additionally, studies indicated miR-183-5p and miR-149-5p inhibit the release of progesterone and estradiol, respectively [17]. Moreover, miR-509-3p promotes estradiol secretion by targeting MAP3K8 [60].

In summary, up to date many miRNAs mediate the process of oocyte maturation and folliculogenesis and also regulate follicular atresia through their target genes, thereby modulating FGCs apoptosis [59]. A large number of miRNAs and miRNA clusters involved in the FD have been documented [61–63]. However, accurate roles of miRNAs and miRNA clusters in this process are not clearly understood [8,63]. Understanding the miRNAs roles will elucidate clearly the mechanisms of GC apoptosis, development and atresia of ovarian follicles [64].

MiRNA CLUSTERS REGULATE FGCs APOPTOSIS AND FOLLICULAR DEVELOPMENT

A miRNA cluster comprises of more than two miRNAs with similar functions [65]. Currently, it has been reported that the specific miRNA families and clusters are involved in follicular atresia and development including miR-21, miR-23a, miR-145, miR-503, miR-224, miR-383, miR-378, miR-132, miR-212, the let-7 family, miR-17-92 cluster, miR-23-27-24 cluster, miR-183-96-182 cluster, miR-17-92 cluster and so on [28,64,66,67]. However, it has been undetermined which miRNA cluster(s) are associated with the each stage of FD [61,63,64]. Furthermore, actual roles of these miRNA clusters in the FD, atresia and ovulation remain unclear [8,43,68].

Fifteen different miRNAs were found during the growth and selection of dominant follicles [69]. Six miRNAs, including miR-17, miR-18a, miR-19a, miR-20a, miR19b, and miR-92a, are encoded by a single miR-17-92 transcript [70], and are expressed and processed together as a cluster [63]. The miR-17-92 cluster was differentially expressed in GCs from subordinate and dominant follicles at day 19 of the estrous cycle [71]. The overexpression of the miR-17-92 cluster promoted GC proliferation and reduced the proportion of differentiated cells. However, miR-17-92 cluster inhibition resulted in decreased proliferation and increased differentiation in GCs [71].

The miR-183-96-182 cluster (miR-183, miR-96, and miR-182) is highly conserved [72], it is also abundantly expressed in both luteal cells and bovine FGCs of preovulatory dominant follicles [20,73]. This miRNAs cluster impacted bFGCs proliferation. The overexpression of miR-183-96-182 promoted the proliferation of bovine FGCs [20]. This cluster targeted the 3′-UTR of the FOXO1 gene [74], and thus regulated FD and luteal development via exerting effects on cell survival and steroid production. Moreover, it was also reported miR-182 inhibited FGCs apoptosis by targeting SMAD7. However, the actual roles and mechanism of miRNAs remain to be comprehensively investigated in the FGCs apoptosis and follicular atresia [8,75,76].

The miR-23-27-24 cluster comprises the miR-23a gene cluster (miR-23a, miR-27a, and miR-24-2 genes) and the miR-23b cluster (mir-23b, mir-27b, and mir-24-1 genes) that exert their function via SMAD5. SMAD5 is a direct target of mir-23a and mir-27a, which promote GC apoptosis via the Fas-FasL pathway [59]. These evidences suggest that miR-23-27-24 clusters play a role in follicular atresia. On the other hand, expression levels of miR-23a-27a-24, miR-222-221, and miR-214-199a clusters showed an increase until the mid-luteal phase, but expression decreased in the dominant FGCs during the late follicular phase of the estrous cycle.

The miR-17-92 cluster (including miR-17, miR-18a, miR-19a, miR-19b, miR-20a, and miR-92a) was activated via direct binding the MYCN proto-oncogene/MYC proto-oncogene promoter [64,77]. This cluster showed to regulate the transforming growth factor β (TGFβ) pathway and affect FGCs apoptosis and follicular atresia [70]. Similarly, the miR-132-212 cluster is associated with ovulation and was elevated after the induction with an ovulatory dose of LH/human chorionic gonadotropin [16], preventing cells from entering into apoptosis.

Based on the reported information in recent years, the regulatory roles of miRNAs on FGCs are summarized in Table 1. As presented in table 1, in total of 41 academic theses regarding 34 miRNAs and miRNAs clusters that reported the regulatory effects of miRNAs on FGCs apoptosis in mammals. The documents indicated explicitly that 24 miRNAs and miRNAs clusters in 29 articles promoted or induced FGCs apoptosis through their distinctive target genes. Seven miRNAs inhibited FGCs apoptosis. So far, the regulatory roles of the remaining 9 miRNAs and miRNAs clusters have been undetermined. We could conclude that a majority of miRNAs show promoting role on apoptosis of FGCs in mammals. But the accurate mechanism of miRNAs and miRNA clusters have been not well understood.

Table 1.

Regulatory roles of miRNAs on apoptosis of granulosa cells

Gene symbol	Functions and changes during apoptosis	Target genes	Model species	Study types	References
miR-21	Decreased cleaved caspase 3, inhibited apoptosis, increases ovulation rate	LNA-21	Mice	In vivo	Carletti [14]
miR-182	Inhibits FGCs apoptosis	SMAD7	Human	In vitro	Sinha [47]
miR-23a	Increased cleaved caspase-3, decreased caspase-3 protein and promoted FGC apoptosis	XIAP (protein)	Human	In vitro	Yang [58]
	Promoted FGCs apoptosis in human	SMAD5	Human	In vitro	Nie [59]
miR-26b	Increases DNA break, inhibits ATM, and promotes FGC apoptosis	ATM	Pig	In vitro	Liu [37]
	Inhibits Bcl-2, suppresses SMAD4, and promotes GC apoptosis	SMAD4	Pig	In vitro	Liu [37]
	Suppresses HAS2, enhances caspase-3 and promotes GC apoptosis	HAS2	Pig	In vitro	Liu [84]
miR-34a	Represses INHBB and promotes GC apoptosis	INHBB	Pig	In vitro	Tu [90]
miR-92a	Inhibits SMAD7 and promotes apoptosis	SMAD7	Pig	In vitro	Liu [83]
miR-27a	Increases expression of cleaved caspase-8, cleaved caspase-3, promotes FGC apoptosis	SMAD5	Human	In vitro	Nie [59]
let-7g	Inhibits MAPK1 and induces GC apoptosis	MAP3K1	Pig	In vitro	Zhou [25]
	Inhibits TGB-β1 and induces GC apoptosis	TGBR1	Pig	In vitro	Cao [26]
	Induces FGCs apoptosis	MAP3K1	Pig		Cao [32]
	Overexpression of let-7g increase the apoptosis rate of FGCs	IGF1R	Mice	In vitro	Zhou [23]
miR-125a	Enhances cleaved caspase-3 and promotes FGC apoptosis	STAT3	Mice	In vitro	Wang [70]
miR-320	Inhibits E2 synthesis and FGC proliferation	E2f1/Sf-1	Mouse	In vitro	Andrei [43]
miR-15a	promotes release of progesterone and testosterone	unknown	Human	In vitro	Sirotkin [17]
miR-146a	Inhibits ovarian granulosa cell apoptosis	IRAK1	Human	In vivo	Chen [34]
miR-146a-5p	Promotes apoptosis of mural gcs	IRAK1 TRAF6	Human	In vivo	Lei [48]
miR-125a-5p	Promotes GC apoptosis	Stat3	Mouse	In vitro	Andrei [43]
miR-126*	Inhibits FSHR expression and increases the rate of AR-induced apoptosis in FGCs	FSHR	Pig	In vitro	Du [35]
miR-378	Decreases E2 production	CYP19A1	Porcine	In vitro	Xu [57]
miR-378-3p	Inhibited FGC differentiation	PGR	Bovine	In vitro	Sun [21]
miR-224	Enhanced TGF-1-induced FGC proliferation	TGF-1 Smad4	Mice	In vitro	Shin [13]
miR-10	Suppresses GC proliferation	BDNF	Goat	In vivo	Andrei [43]
miR-503/322/351 cluster	Reduces of mitochondrial activity in FGCs	AMAG	Mouse	In vitro	Lei [48]
miR-764-3p	Decreases steroidogenesis	Sf-1	Mice	In vitro	Wang [70]
miR-22	Suppresses SIRT1 and inhibits FGCs apoptosis	SIRT1	Mice	In vitro	Xiong [86]
miR-183-96-182 cluster	Promotes GCs apoptosis	FOXO1	Cow	In vitro	Gebremedhn [73]
miR-17-92 cluster	Promoted GCs proliferation	PTEN BMPR2	Cattle	In vitro	Andreas [71]
	Affect FGCs apoptosis and follicular atresia	MYCN/ MYC	Mice		Wang [70]
MiR-141-3p	Inhibits apoptosis in rat ovarian GCs	DAPK1	Rat	In vitro	Li [33]
miR-145	Regulates negatively FGC proliferation	IRS1	Human	In vitro	Naji [28]
	Protects FGCs agaist oxidative stress- induced apoptosis	KLF4	Mice	In vitro	Zhang [64]
miR-378	Increases apoptosis rate	Bax/Bcl-2	Mice	In vitro	Sun [21]
miR-16	Suppresses Apoptosis through targeting PDCD4 in polycystic ovarian syndrome	PDCD4	Human	In vivo	Fu [30]
miR-125b	Regulates apoptosis of FGCs	BMPR1B	Yak	In vivo	Yao [38]
miR-1275	Promoted early apoptosis of FGCs	LRH-1	Pig	In vitro	Liu [40]

LNA-21, locked nucleic acid; FGCs, follicular granulosa cells; SMAD4, SMAD5, and SMAD7, Sma-and Mad-related 4, 5 and 7, respectively; XIAP, X-linked inhibitor of apoptosis protein; ATM, ataxia telangiectasia mutated gene; GCs, granulosa cells; HAS2, hyaluronic acid synthase 2; INHBB, inhibin beta-B; MAP3K1, mitogen-activated protein kinase kinase kinase 1; TGB-β1, transforming growth factor-β type 1; TGBR1, transforming growth factor-β type 1 receptor; IGF1R, insulin-like growth factor 1 receptor; STAT3, signal transducer and activator of transcription 3; IRAK1, interleukin-1 receptor-associated kinase; TRAF6, tumor necrosis factor receptor-associated factor 6; FSHR, FSH receptor; CYP19A1, cytochrome P450, family 19, subfamily A, polypeptide 1; PGR, progesterone receptor; TGF-1, transforming growth factor 1; Smad2, Sma- and Mad-related protein 2; BDNF, brain derived neurotrophic factor; AMAG, autophagy/mitophagy-associated genes; Sf-1, steroidogenic factor-1; SIRT1, silent mating-type information regulation 2 homologue 1; FOXO1, fork head O1; PTEN, phosphatase and tensin homolog deleted on chromosome ten; BMPR, bone morphogenetic protein receptor 1b; MYCN/MYC, Mycn proto-oncogene/Myc proto-oncogene; DAPK1, death-associated protein kinase 1; IRS1, insulin receptor substrate; KLF4, Krüppel-like factor 4; Bax/Bcl-2, B-cell lymphoma-2 associated X/B-cell lymphoma-2; PDCD4, programmed cell death 4; BMPR1B, argeting bone morphogenetic protein receptor 1B; LRH-1, liver receptor homolog-1.

MOLECULAR SIGNALING PATHWAYS WERE SUMMARIZED

The existence of miRNAs was discovered more than 20 years ago, and since then considerable achievements have been made in understanding the molecular mechanisms in the apoptosis, proliferation and development of follicular cells [78]. MiRNAs can combine with complementary sequences in the 5′-UTR [52] or 3′-UTR [21] of target mRNAs, therefore degrading the mRNA or repressing translation.

Nowadays, it has been known that many miRNAs modulate and FGCs apoptosis and follicular atresia through distinct signaling pathways [61]. Individual miRNAs target multiple genes and involve different patterns of pathways to regulate apoptosis of FGCs, follicular atresia and development. The miRNAs regulate varying signaling pathways of FGCs apoptosis and the ensuing FA via interacting with the mRNAs of target genes [37,58]. Several miRNAs targeting signaling pathways of FGCs apoptosis have been identified in bovine FGCs [20,79]. A previous report showed that at least 77 signaling pathways were reported in the documents which involved miRNAs regulation on FGCs apoptosis and FD [8]. Another study indicated 10 differentially expressed miRNAs and 117 pathways in dominant follicles were collected [51]. An earlier bioinformatic analysis of miRNAs expression of FGCs showed that 139 associated pathways were screened out during the growth and selection of dominant follicles [69]. Furthermore, Cha et al 83 reported that 48 signal transduction pathways are up-regulated by miRNAs and 29 pathways are down-regulated by the miRNAs [80]. Nowdays, it has been clearly undetermined how many signal transduction pathways are involved in the miRNAs regulation roles [8,64]. Based on the documents, partial miRNAs and their signal pathways are summarized in Table 2. As shown in this table, 16 miRNAs exert their functions by targeting 11 genes (mainly SMAD7) via mainly 11 signal pathways with the maximum of TGF-β and Bcl-2 (Figure 1).

Table 2.

miRNAs and their signal pathways

Signal pathway	mi-RNAs	Target	Model Species	Reference
TGF-β	miR-92a	SMAD7	Mouse	Yang [55]
			Human	Donadeu [56]
	miR-181b	SMAD7	Pig	Yao [38]
	miR-let-7g	TGBR1	Pig	Zhou [25]
	miR-92a	SMAD7	Pig	Liu [37]
	miR-182	SMAD7	Rat	Luo [15]
	miR-224	SMAD4	Mice	Yao [38]
Bcl-2	miR-26b	SMAD4	Pig	Worku [49]
	miR-26b	ATM	Pig	Liu [84]
	miR-let-7g	MAP3K1	Porcine	Cao [32]
	miR-224	SMAD4	Pig	Liu [37]
Bcl-2/Bax	miR-125b	BMPR1B	Yak	Yao [38]
Bcl-2/MCL-1	miR-let-7g	TGBR1	Pig	Cao [32]
FasL-Fas	miR-23a miR-27a	SMAD5	Human	Nie [59]
TGFBR1	miR-125b	SMAD7	Pig	Yao [38]
HAS2-CDD44-casp-3	miR-26b	SMAD4	Pig	Liu [84]
		USP9X		Liu [37]
HAS2-HA-cd44-casp-3	miR-26b	HAS2	Pig	Liu [84]
sNPFR1/npyr	miR-9a	NPY2R	Porcine	Suh [54]
MSK1	miR-130	SMAD5	Cattle	Sinha [47]
PKB/mTOR	miR-let-7g	IGF1R	Mice	Zhou [23]
CP2/miR-144/COX-2/PGE2	miR-144	CP2	Mouse	Zhou [39]

TGF-β, transforming growth factor β; SMAD4, SMAD5, and SMAD7, Sma-and Mad-related 4, 5 and 7, respectively; TGBR1, transforming growth factor-beta type 1 receptor; Bcl-2, B-cell lymphoma-2; ATM, ataxia telangiectasia mutated; MAP3K1, mitogen-activated protein kinase kinase kinase 1; BMPR1B, argeting bone morphogenetic protein receptor 1B; MCL-1, myeloid cell leukemia-1 gene; TGFBR1, threonine kinase complex composed of type I; HAS2, hyaluronan synthase 2; HA, hyaluronic acid; ubiquitin-specific proteases 9X (USP9X); sNPFR1, short neuropeptide F receptor 1; NPY2R, Neuropeptide Y receptor Y2; MSK1, mitogen- and stress-activated protein kinase 1; IGF1R, insulin-like growth factor 1 receptor; CP2, cyclooxygenase prostaglandin E2; COX, cyclooxygenase; PGE2, prostaglandin.

Figure 1.

The main target genes and numbers of miRNAs regulatory roles on follicular granulosa cells (FGCs) apoptosis (articles published untill March 2019). The diverse types of miRNAs regulated FGCs apoptosis of and follicular development in humans and animals. But, which target gene is the key gene in these comprehensive processes so far has been undetermined.

Moreover, the SMAD played an important role in regulating FD [51,81]. SMAD proteins can transduce the TGF-β family signals at the cell surface into gene regulation in the nucleus. The miR-23a and miR-27a targeted SMAD5 and regulated apoptosis in human GCs via the FasL-Fas pathway [59].

The miR-224 and miR-26b regulate the pathway by targeting SMAD4 [13,82]. Earlier research indicated that miR-26b was upregulated during porcine follicular atresia. In vitro study revealed miR-26b enhanced DNA breaks and GC apoptosis by targeting ATM [83]. Overexpression of miR-26b in follicular FGCs suppressed levels of SMAD4 mRNA and protein, leading to down-regulation of the antiapoptosis Bcl-2 gene and the promotion of GC apoptosis [49]. Another study reported that miR-26b and its overexpression could promote apoptosis of porcine FGCs by directly and indirectly targeting SMAD4, ubiquitin-specific proteases 9X and hyaluronic acid synthase 2 (HAS2) respectively [83]. The apoptosis processes are mediated through the HAS2-CDD44-Caspase-3 pathway [84]. These results strongly suggested that miR-26b plays a crucial role in GC apoptosis and follicular atresia.

The miR-23a and miR-27a promote human GC apoptosis by targeting SMAD5. Similarly, miR-92a, miR-181b, and miR-182 directly bind to SMAD7 [47,76], which is considered an antagonist of the TGFβ pathway [17] and an amplifier of TGFβ-induced apoptosis [24]. Roles of the TGFβ pathway and related miRNA regulation have been frequently reported in recent years.

The functional networks play critical roles in the FD which contribute to the profound exploration on miRNAs roles. However, the association with downstream apoptosis genes and proteins remains still unclear [85,86]. The exact signal pathways in which the miRNAs exert need to be investigated in the future [40].

CONCLUSIONS AND PERSPECTIVES

MiRNAs are involved in physiological and developmental processes by post-transcriptionally inhibiting gene expression. In this review of 41 academic theses, we summarize the current advances in the regulatory roles of miRNAs and miRNA clusters on the FGCs apoptosis and FD in the mammals. Total of 30 miRNAs and 4 miRNAs clusters were reported in all articles. The documents indicated explicitly that 24 miRNAs and miRNAs clusters in 29 articles promoted or induced FGCs apoptosis through their distinctive target genes. The remaining 12 papers reported that 10 miRNAs and miRNAs clusters inhibited FGCs apoptosis. We could conclude that miRNAs or miRNAs clusters could modulate the apoptosis of GCs (including follicular GCs, mural GCs, and cumulus cells) by targeting its specific genes through the different signal pathway. A majority of miRNAs show promoting role on apoptosis of FGCs in mammals. But the accurate mechanism of miRNAs and miRNA clusters is not well understood [8,43,64]. The current results in the published documewnts are still not to clearly eaplain the distinctive effects of each miRNAs or miRNA cluster on FGCs apoptosis and FD in mamnals. It is extremely necessary to ascertain clearly the role and mechanism of each miRNA or miRNA cluster in the future. Understanding comprehensively mechanism of miRNA action may enhance the development of new tools to study miRNAs functions and inspire new diagnostic and treatment strategy or scheme for infertility [87], ovarian disorders and ovarian diseases associated to miRNA high expression or insufficiency [88], such as follicular infertility and ovarian cancer [89].